JS

Jeffrey Schlom

US US Dept of Health & Human Services: 25 patents #9 of 3,044Top 1%
GL Globeimmune: 15 patents #5 of 23Top 25%
The Dow Chemical: 5 patents #698 of 4,115Top 20%
TB Therion Biologics: 4 patents #6 of 14Top 45%
NI NIH: 1 patents #22 of 259Top 9%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
📍 Potomac, MD: #6 of 998 inventorsTop 1%
🗺 Maryland: #77 of 35,612 inventorsTop 1%
Overall (All Time): #20,007 of 4,157,543Top 1%
85
Patents All Time

Issued Patents All Time

Showing 26–50 of 85 patents

Patent #TitleCo-InventorsDate
9623097 Yeast-brachyury immunotherapeutic compositions Claudia M. Palena, Zhimin Guo, David Apelian 2017-04-18
9533031 Yeast-MUC1 immunotherapeutic compositions and uses thereof Alex Franzusoff, Zhimin Guo, Kwong-Yok Tsang 2017-01-03
9370559 Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Kwong-Yok Tsang 2016-06-21
9198941 Yeast-Brachyury immunotherapeutic compositions Claudia M. Palena, Zhimin Guo, David Apelian 2015-12-01
9175057 Immunogenic peptides and methods of use Kwong-Yok Tsang, Ira H. Pastan 2015-11-03
8957192 Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Kwong-Yok Tsang 2015-02-17
8933041 System for treating and preventing breast cancer Dennis L. Panicali, Gail P. Mazzara, Linda R. Gritz, Kwong-Yok Tsang, James Hodge 2015-01-13
8901093 Custom vectors for treating and preventing pancreatic cancer Dennis L. Panicali, Gail P. Mazzara, Linda R. Gritz, Kwong-Yok Tsang, James Hodge 2014-12-02
8883448 Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes Scott Abrams 2014-11-11
8835167 Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors Syed V. S. Kashmiri, Eduardo A. Padlan 2014-09-16
8828717 Framework residue substituted humanized COL-1 antibodies and their use Syed V. S. Kashmiri, Eduardo A. Padlan 2014-09-09
8748390 Immunogenic epitopes of NGEP antigen Kwong-Yok Tsang, Ira H. Pastan 2014-06-10
8613933 Brachyury polypeptides and methods for use Claudia M. Palena, Andrei P. Kozlov, Kwong-Yok Tsang 2013-12-24
8609395 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) Elene Barzaga, Sam Zaremba 2013-12-17
8535890 Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies Syed V. S. Kashmiri, Eduardo A. Padlan 2013-09-17
8188214 Brachyury polypeptides and methods for use Claudia M. Palena, Andrei P. Kozlov, Kwong-Yok Tsang 2012-05-29
8178508 Methods of stimulating an immune response against prostate specific antigen Kwong-Yok Tsang, Sam Zaremba 2012-05-15
8029788 Variants of humanized anti-carcinoma MAb CC49 Syed V. S. Kashmiri, Eduardo A. Padlan 2011-10-04
7999071 Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1 Kwong-Yok Tsang 2011-08-16
7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies Syed V. S. Kashmiri, Eduardo A. Padlan 2011-04-05
7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 Syed V. S. Kashmiri, Eduardo A. Padlan 2011-03-29
7910692 Immunogenic peptides and methods of use Kwong-Yok Tsang, Ira H. Pastan 2011-03-22
7871986 Methods of stimulating an immune response against prostate specific antigen Kwong-Yok Tsang, Sam Zaremba 2011-01-18
7855276 Framework residue substituted humanized COL-1 antibodies and their use Syed Kasmiri, Eduardo A. Padlan 2010-12-21
7771715 Recombinant vector expressing multiple costimulatory molecules and uses thereof James Hodge, Dennis L. Panicali 2010-08-10